iShares Biotechnology ETF | IBBRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 31-03-2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | 15,6 | 8,6 | -8,0 | 0,2 | 3,4 | |
+/-Cat | -1,5 | -6,4 | 1,6 | 0,5 | -5,4 | |
+/-Idx | 9,0 | -18,9 | 5,0 | -17,8 | -7,3 | |
Categorie: Health | ||||||
Categorie Benchmark: MSCI ACWI NR USD |
Kerngegevens | ||
slotkoers 25-04-2024 | USD 125,67 | |
Rendement 1 Dag | -1,86% | |
Morningstar Categorie™ | Health | |
Vestigingsland | Verenigde Staten | |
Volume | 1384938 | |
Beurs | NASDAQ | |
ISIN | US4642875565 | |
Grootte Fonds (Mil) - | - | |
Grootte Fondsklasse (Mil) 25-04-2024 | USD 6952,01 | |
Lopende Kosten Factor - | -% |
Morningstar Research |
Beleggingsdoelstelling: iShares Biotechnology ETF | IBB |
The investment seeks to track the investment results of the NYSE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified. |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Greg Savage 01-01-2008 | ||
Jennifer Hsui 01-08-2012 | ||
Click here to see others | ||
Oprichtingsdatum 05-02-2001 |
Advertentie |
Categorie Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
NYSE Biotechnology TR USD | MSCI ACWI NR USD |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? iShares Biotechnology ETF | IBB | 23-04-2024 |
|
|
Top 5 posities | Sector | % |
Amgen Inc | Gezondheidszorg | 8,65 |
Vertex Pharmaceuticals Inc | Gezondheidszorg | 8,33 |
Regeneron Pharmaceuticals Inc | Gezondheidszorg | 8,13 |
Gilead Sciences Inc | Gezondheidszorg | 8,05 |
IQVIA Holdings Inc | Gezondheidszorg | 4,52 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
iShares Biotechnology ETF | IBB |